157 related articles for article (PubMed ID: 2138654)
1. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Walsh TJ; Aoki S; Mechinaud F; Bacher J; Lee J; Rubin M; Pizzo PA
J Infect Dis; 1990 Apr; 161(4):755-60. PubMed ID: 2138654
[TBL] [Abstract][Full Text] [Related]
2. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts.
Walsh TJ; Lee J; Aoki S; Mechinaud F; Bacher J; Lecciones J; Thomas V; Rubin M; Pizzo PA
Rev Infect Dis; 1990; 12 Suppl 3():S307-17. PubMed ID: 2184509
[TBL] [Abstract][Full Text] [Related]
3. SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Walsh TJ; Lee JW; Lecciones J; Kelly P; Peter J; Thomas V; Bacher J; Pizzo PA
Antimicrob Agents Chemother; 1990 Aug; 34(8):1560-4. PubMed ID: 2221866
[TBL] [Abstract][Full Text] [Related]
4. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases.
Walsh TJ; Lee JW; Roilides E; Francis P; Bacher J; Lyman CA; Pizzo PA
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S139-47. PubMed ID: 1562687
[TBL] [Abstract][Full Text] [Related]
5. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
6. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
7. [Candidiasis of the liver following successful chemotherapy of acute myeloid leukemia (Fab type 6) and recovery with oral fluconazole therapy].
Keiser G; Schmid M; Ishak KG; Wirth W; Vogt M
Schweiz Med Wochenschr; 1996 Apr; 126(17):713-7. PubMed ID: 8668982
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits.
Filler SG; Crislip MA; Mayer CL; Edwards JE
Antimicrob Agents Chemother; 1991 Feb; 35(2):288-92. PubMed ID: 2024963
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
Atkinson BA; Bouthet C; Bocanegra R; Correa A; Luther MF; Graybill JR
J Antimicrob Chemother; 1995 May; 35(5):631-40. PubMed ID: 7592176
[TBL] [Abstract][Full Text] [Related]
12. Candida and Aspergillus infections in immunocompromised patients: an overview.
Saral R
Rev Infect Dis; 1991; 13(3):487-92. PubMed ID: 1866554
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic candidiasis: successful treatment with fluconazole.
Kauffman CA; Bradley SF; Ross SC; Weber DR
Am J Med; 1991 Aug; 91(2):137-41. PubMed ID: 1867239
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis.
Longman LP; Hibbert SA; Martin MV
Rev Infect Dis; 1990; 12 Suppl 3():S294-8. PubMed ID: 2184507
[TBL] [Abstract][Full Text] [Related]
15. Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Ponnuvel KM; Rama CP; Menon T
Indian J Exp Biol; 1993 May; 31(5):450-2. PubMed ID: 8359853
[TBL] [Abstract][Full Text] [Related]
16. In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
Chavanet P; Duong M; Buisson M; Hamel H; Dubois C; Bonnin A; Portier H
J Antimicrob Chemother; 1997 Mar; 39(3):427-30. PubMed ID: 9096196
[TBL] [Abstract][Full Text] [Related]
17. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
Anaissie E; Bodey GP; Kantarjian H; David C; Barnett K; Bow E; Defelice R; Downs N; File T; Karam G
Am J Med; 1991 Aug; 91(2):142-50. PubMed ID: 1867240
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Groll AH; Petraitis V; Petraitiene R; Field-Ridley A; Calendario M; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 1999 Oct; 43(10):2463-7. PubMed ID: 10508025
[TBL] [Abstract][Full Text] [Related]
20. Invasive candidiasis during granulocytopenia.
Anaissie E; Pinczowski H
Recent Results Cancer Res; 1993; 132():137-45. PubMed ID: 8265854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
